Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)
A Global Perspective on Cardiovascular Risk Factors by Educational Level in CHD Patients: SURF CHD II
Artificial intelligence based data curation: enabling a patient-centric European health data space
Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper.
Influence of non-refrigerated urine storage time on stability of urine particles
Real-world data on the use of emicizumab in pediatric patients in Baltic countries
Situation of laboratory diagnostics of bleeding disorders in Baltic countries
Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)
Eesti perekondliku hüperkolesteroleemia käsitlusjuhend
The Hypertension Excellence Centre programme of the European Society of Hypertension – current status, activities and reshaping for the future
Uut südamehaiguste ennetamises diabeetikutel Euroopa Kardioloogide Seltsi 2023. aasta ravijuhendis
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network